New weight loss pill enters final testing phase
NCT ID NCT06939296
Summary
This study is testing whether a new pill called VCT220 helps people lose weight and keep it off. About 840 overweight or obese adults will take either a high dose, low dose, or a placebo pill once a day for a full year. Researchers will measure changes in body weight, waist size, and other health markers to see if the treatment is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital （ There are multiple sites in this clinical trial）
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.